| Literature DB >> 27272212 |
Lina Lu1,2, Bo Lv1, Kevin Huang3, Zhigang Xue1, Xianmin Zhu2, Guoping Fan4,5.
Abstract
Preimplantation genetic diagnosis/screening (PGD/PGS) aims to help couples lower the risks of transmitting genetic defects to their offspring, implantation failure, and/or miscarriage during in vitro fertilization (IVF) cycles. However, it is still being debated with regard to the practicality and diagnostic accuracy of PGD/PGS due to the concern of invasive biopsy and the potential mosaicism of embryos. Recently, several non-invasive and high-throughput assays have been developed to help overcome the challenges encountered in the conventional invasive biopsy and low-throughput analysis in PGD/PGS. In this mini-review, we will summarize the recent progresses of these new methods for PGD/PGS and discuss their potential applications in IVF clinics.Entities:
Keywords: Embryo biopsy; In vitro fertilization (IVF); Non-invasive testing; Preimplantation genetic diagnosis (PGD); Preimplantation genetic screening (PGS)
Mesh:
Year: 2016 PMID: 27272212 PMCID: PMC5010808 DOI: 10.1007/s10815-016-0750-0
Source DB: PubMed Journal: J Assist Reprod Genet ISSN: 1058-0468 Impact factor: 3.412